Ignite Creation Date:
2024-10-25 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06633666
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-05
Brief Title:
Acupuncture for Post COVID-19 Condition Long COVID Neuropsychiatric Symptoms
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Acupuncture for Long COVID Neuropsychiatric Symptoms a PragmaticRandomized Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study a 12-week pragmatic randomized double-blinded clinical trial will be conducted to evaluate the efficacy of acupuncture for the treatment of long Covid neuropsychiatric symptoms and provide reference for clinical non-drug treatment
Detailed Description:
This is a pragmatic randomized double-blinded clinical trial on acupuncture for treating neuropsychiatric symptoms in long Covid patients A total of 160 participants will be diagnosed by a registered Chinese medicine practitioner and randomly assigned to the acupuncture and the control group with a 11 ratio The acupuncture group will receive 60 sessions of interventions during a 12-week treatment duration 2 sessions per week and will be followed up at week 18 The control group will only receive conventional therapy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None